Hca Healthcare Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Hca Healthcare Inc 's ROA in the third quarter of 2026?
Hca Healthcare Inc achieved a return on average assets (ROA) of 9.2 % in its third quarter of 2026, which is below Hca Healthcare Inc 's average return on assets, which stands at 10.46%.

ROA decreased relative to the period ending Jun 30 2026, due to the decline in net income.

However, within the Healthcare sector 80 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 448, from total ROA ranking in the second quarter of 2026 at 503.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	63.17 %	62.44 %	3.41 %	6.66 %	4.35 %
Y / Y Net Income Change	-17.03 %	-10.15 %	1.75 %	28.29 %	28.41 %
Net Income (TTM) in million	7,298	7,622	7,814	7,782	7,305
Return On Assets (TTM)	9.2 %	10.91 %	12.9 %	12.95 %	12.36 %
HCA's Total Ranking	# 448	# 503	# 480	# 500	# 522
Total Assets (TTM) in million	97,489	96,712	61,837	61,205	59,747
Seq. Total Assets Change	0.8 %	56.4 %	1.03 %	2.44 %	0.35 %
Seq. Net Income Change	-7.06 %	-8.51 %	-14.15 %	13.66 %	0.63 %

HCA's 5 Years Annual ROA >> Back to HCA Management Effectiveness >> Compare HCA ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 3
Sector	# 81
Overall	# 502

Return On Assets Statistics
High	Average	Low
15.78 %	10.46 %	6.54 %
(Dec 31 2021)		(Mar 31 2013)

Financial Statements
Hca Healthcare Inc 's Assets	$ 97,489 million	HCA's Balance sheet
Hca Healthcare Inc 's Income	$ 1,579 million	Quarterly HCA's Income Statement
HCA's Income by Division		See HCA's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	6.66 %	6.26 %	7.21 %	3.59 %	6.96 %
Total Assets in million	61,205	57,382	54,004	50,373	48,629
Y / Y Net Income Change	16.9 %	9.29 %	-10.87 %	-11.49 %	76 %
Net Income in million	7,782	6,657	6,091	6,834	7,721
Annual Return On Assets	12.71 %	11.6 %	11.28 %	13.57 %	15.88 %

HCA's 5 Years Annual ROA >> Back to HCA Management Effectiveness >> Compare HCA ROA to its Competitors

Comment on HCA's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 12.71 % compared to prior year, due to annual net income growth of 16.9 % to $7,782.00 million, while value of Hca Healthcare Inc 's overall assets grew just by 6.66 % to $61,205.00 million, compared to $61,205.00 a year before.

More Return On Assets Ratios
HCA's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
HCA's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for HCA's Competitors
Subscribers only: Roa for Hca Healthcare Inc 's Suppliers
Subscribers only: Return On Assets for HCA's Customers

You may also want to know
HCA's Roi	HCA's Inventory Turnover Ratio	HCA's Growth Rates	HCA's Dividend Comparisons
	HCA's Profitability Ratios	HCA's Asset Turnover Ratio	HCA's Dividend Growth
HCA's Roe	HCA's Valuation Ratios	HCA's Financial Strength Ratios	HCA's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Medpace Holdings Inc	24.47 %
Acadia Pharmaceuticals Inc	21.60 %
Standard Biotools Inc	21.56 %
Eli Lilly And Company	21.24 %
Iradimed Corporation	20.89 %
Resmed Inc	18.67 %
Alector Inc	18.37 %
Corcept Therapeutics Inc	18.09 %
Chemed Corporation	17.73 %
Halozyme Therapeutics Inc	17.26 %
Pro dex Inc	16.75 %
Denali Therapeutics Inc	16.42 %
Krystal Biotech Inc	15.48 %
West Pharmaceutical Services Inc	15.47 %
Dexcom Inc	15.47 %
Intuitive Surgical Inc	14.71 %
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %
Inspire Medical Systems inc	10.89 %
Transmedics Group Inc	10.67 %

Date modified: 2026-10-30T14:39:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.